Phillips L L
Clin Haematol. 1984 Feb;13(1):137-50.
Transfusion support for acquired coagulation defects can be life-saving when used correctly. There should be laboratory evidence of such defects combined with clinical evidence of excessive bleeding. The laboratory values alone should not be treated except in preparation for an invasive procedure. Then plasma defects are best treated with fresh frozen plasma immediately before surgery since many of the factors have short half-lives. Platelet infusions are better withheld until the platelet-destroying features of some surgical procedures are completed, as in splenectomy or extracorporeal circulation.
对获得性凝血缺陷进行输血支持如果使用得当可挽救生命。应有此类缺陷的实验室证据并伴有出血过多的临床证据。仅实验室检查结果不应进行治疗,除非是为有创操作做准备。对于血浆缺陷,最好在手术前立即输注新鲜冰冻血浆,因为许多凝血因子半衰期较短。血小板输注最好推迟到某些手术操作(如脾切除术或体外循环)破坏血小板的过程结束之后。